LuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC)

被引：0

作者：

Sandhu, Shahneen

Joshua, Anthony M.

Emmett, Louise

Crumbaker, Megan

Bressel, Mathias

Huynh, Rhonda

Banks, Patricia Diana

Wallace, Roslyn

Hamid, Anis

Inderjeeth, Andrisha Jade

Tran, Ben

Azad, Arun

Alipour, Ramin

Kong, Grace

Kumar, Aravind Ravi

Saghebi, Javad

Williams, Scott

Akhurst, Timothy J.

Hicks, Rodney J.

Hofman, Michael S.

机构：

[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[3] St Vincents Hosp, Sydney, NSW, Australia

[4] Peter MacCallum Canc Ctr, Ctr Biostat & Clin Trials, Melbourne, Vic, Australia

[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[6] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia

[7] Peter MacCallum Canc Ctr, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic, Australia

[8] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia

[9] Univ Melbourne, St Vincents Med Sch, Melbourne, Vic, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5005

引用

页数：1